JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 163 filers reported holding JUNO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.51 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $359,000 | -43.9% | 7,860 | -44.9% | 0.45% | +423.3% |
| Q3 2017 | $640,000 | +65.4% | 14,261 | +10.1% | 0.09% | +48.3% |
| Q2 2017 | $387,000 | +11.5% | 12,957 | -17.2% | 0.06% | -6.5% |
| Q1 2017 | $347,000 | +30.0% | 15,654 | +10.6% | 0.06% | -22.5% |
| Q4 2016 | $267,000 | +47.5% | 14,153 | +135.2% | 0.08% | -9.1% |
| Q3 2016 | $181,000 | -21.6% | 6,017 | 0.0% | 0.09% | -48.5% |
| Q2 2016 | $231,000 | +13.2% | 6,017 | +12.4% | 0.17% | -39.1% |
| Q1 2016 | $204,000 | – | 5,353 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 2,168,601 | $65,080,000 | 86.12% |
| Crestline Management, LP | 17,348,799 | $520,637,000 | 66.02% |
| Omega Fund Management, LLC | 1,229,512 | $36,898,000 | 28.17% |
| SIB LLC | 100,000 | $3,001,000 | 2.42% |
| Clarius Group, LLC | 117,896 | $3,538,000 | 1.65% |
| BB BIOTECH AG | 1,405,000 | $42,164,000 | 1.48% |
| Duquesne Family Office | 493,000 | $14,795,000 | 1.31% |
| First Washington CORP | 65,320 | $1,960,000 | 1.10% |
| PFM Health Sciences, LP | 1,124,285 | $33,740,000 | 0.99% |
| Partner Investment Management, L.P. | 18,376 | $551,000 | 0.82% |